The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment

B Tai, MM Straus, D Liu, S Sparenborg… - Journal of substance …, 2010 - Elsevier
The National Institute on Drug Abuse established the National Drug Abuse Treatment
Clinical Trials Network (CTN) in 1999 to improve the quality of addiction treatment using …

Barriers to comorbidity service delivery: the complexities of dual diagnosis and the need to agree on terminology and conceptual frameworks

R Canaway, M Merkes - Australian Health Review, 2010 - CSIRO Publishing
This paper draws from a literature review commissioned as part of a larger project
evaluating comorbidity treatment service models, which was funded by the Australian …

Association between mortality rates and medication and residential treatment after in‐patient medically managed opioid withdrawal: a cohort analysis

AY Walley, S Lodi, Y Li, D Bernson… - …, 2020 - Wiley Online Library
Background and aim Medically managed opioid withdrawal (detox) can increase the risk of
subsequent opioid overdose. We assessed the association between mortality following …

Quality of clinical supervision and counselor emotional exhaustion: The potential mediating roles of organizational and occupational commitment

HK Knudsen, PM Roman, AJ Abraham - Journal of substance abuse …, 2013 - Elsevier
Counselor emotional exhaustion has negative implications for treatment organizations as
well as the health of counselors. Quality clinical supervision is protective against emotional …

Cost‐effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs

BR Schackman, JA Leff, DM Barter, MA DiLorenzo… - …, 2015 - Wiley Online Library
Aims To evaluate the cost‐effectiveness of rapid hepatitis C virus (HCV) and simultaneous
HCV/HIV antibody testing in substance abuse treatment programs. Design We used a …

Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS®): Severity of use and positive appeal of use

PA Pilkonis, L Yu, NE Dodds, KL Johnston… - Drug and alcohol …, 2015 - Elsevier
Background Two item banks for substance use were developed as part of the Patient-
Reported Outcomes Measurement Information System (PROMIS®): severity of substance …

Achieving Cannabis Cessation—Evaluating N-acetylcysteine Treatment (ACCENT): Design and implementation of a multi-site, randomized controlled study in the …

EA McClure, SC Sonne, T Winhusen, KM Carroll… - Contemporary clinical …, 2014 - Elsevier
Despite recent advances in behavioral interventions for cannabis use disorders, effect sizes
remain modest, and few individuals achieve long-term abstinence. One strategy to enhance …

[PDF][PDF] A review of screening, assessment and outcome measures for drug and alcohol settings

M Deady - Drug and Alcohol and Mental Health Information …, 2009 - drugsandalcohol.ie
Given the high rates of co-occurring mental health conditions among clients of D&A
treatment services, it is essential that routine screening and assessment be undertaken for …

Use of evidence-based treatments in substance abuse treatment programs serving American Indian and Alaska Native communities

DK Novins, CD Croy, LA Moore… - Drug and alcohol …, 2016 - Elsevier
Background Research and health surveillance activities continue to document the
substantial disparities in the impacts of substance abuse on the health of American Indian …

Buprenorphine adoption in the national drug abuse treatment clinical trials network

HK Knudsen, AJ Abraham, JA Johnson… - Journal of substance …, 2009 - Elsevier
The National Drug Abuse Treatment Clinical Trials Network (CTN), a collaborative federal
research initiative that brings together universities and community-based treatment …